STLN
Starling Oncology
$6.20
−$0.09 (−1.43%)Sep 10, 2026
Key metrics
The numbers that frame STLN today
- Market cap
- $631.88M
- P/E (TTM)
- -15.5
- EV / FCF
- -211.6
- Gross margin
- 15.7%
- EV / Sales
- 1.2
- ROIC
- -23%
- Div yield
- 0%
- 52wk Low
- $2.32
- 52wk High
- $7.05
Growth
Revenue and earnings trend for STLN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about STLN
Is Starling Oncology a good buy?
Yes. Starling Oncology has excellent momentum, and it outweighs the weak quality here. Growth looks strong, which supports the long-term business case. We think Starling Oncology is selling at a high price, which cuts against the buy case.
What is the market capitalization of STLN?
Starling Oncology's market capitalization is $631.88M.
What is the P/E ratio for STLN stock?
Starling Oncology's current P/E ratio is -15.5.
What is the 52-week high for STLN stock?
The 52-week high for Starling Oncology is $7.05. The current close of $6.20 is 12.1% below that high.
What is the 52-week low for STLN stock?
The 52-week low for Starling Oncology is $2.32. The current close of $6.20 is 167.2% above that low.
Does STLN stock pay dividends?
Starling Oncology does not currently show a dividend per share in the company data.